Search

Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan Kettering Cancer Center shows that circulating tumor cells - cancer cells that break away from a primary tumor and disseminate to other areas of the body - can also return to and grow in their tumor of origin, a newly discovered process called "self-seeding."

… Thursday, December 24, 2009 Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan Kettering Cancer Center shows that

… Friday, November 8, 2024 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first three quarters of 2024:   MSK’s financial performance through the third quarter of 2024 demonstrate positive and consistent financial results, with an excess

When comparing options for immediate breast reconstruction after mastectomy, cost analyses should include patient-reported outcome (PRO) measures, such as BREAST-Q scales and complication rates.

… Friday, March 6, 2020 As we move toward alternative payment models for healthcare in the United States, comparative cost analyses need to include the value to patients. When comparing options for immediate breast reconstruction after mastectomy, cost analyses should include patient-reported outcome (

NYC for MSK will unite New Yorkers and some of the most iconic New York brands to commemorate Memorial Sloan Kettering Cancer Center’s 140th Anniversary.

… Wednesday, May 22, 2024 Memorial Sloan Kettering Cancer Center (MSK) announces the launch of  NYC for MSK , celebrating MSK’s 140th anniversary on May 31, 2024. For one day, New York City’s most iconic brands in fashion, food, toys, and sports will come together to support MSK’s mission of ending cancer

Developmental biologist Dr. Alexandra Joyner reflects on her career and talks about the new passions she looks forward to pursuing in retirement.

… Tuesday, March 25, 2025 Alexandra Joyner, PhD , a member of the  Developmental Biology Program in the  Sloan Kettering Institute of Memorial Sloan Kettering Cancer Center (MSK), is retiring this year, following an illustrious 40-plus-year career. An expert in mammalian (mouse) developmental genetics,

In a recent podcast, MSK specialists discussed ways to keep an active sex life during and after cancer treatment.

… Tuesday, July 20, 2021 Cancer and its treatments can cause many changes to the body. One of the most common problems is also the least discussed: the impact on a person’s sexual health. A recent study showed that 87% of cancer survivors experience sexual side effects. But many cancer patients, especially

This year's GSK Chairman’s Prize was awarded to Zhi “Zack” Zheng for his research on the SPO11 protein, which creates double-strand breaks in DNA.

… Wednesday, August 20, 2025 Zhi “Zack” Zheng , who is scheduled to receive his PhD from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) later this year, has received the 2025 Chairman’s Prize. The prize was established by Louis V. Gerstner Jr., the GSK Board of Trustees Chair

Learn how MSK helps patients navigate the intricacies of insurance and financial assistance throughout their cancer treatment.

… Tuesday, October 17, 2023 When Joanna Ihlo learned she had breast cancer , the first thing she worried about was not her health — it was her finances. “I wondered whether I had the right insurance and whether treatment was going to cost me a fortune,” Joanna says. “I have friends who were literally broken

Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer. She also made huge strides in reducing the stigma surrounding the disease.

… Tuesday, January 9, 2018 On Christmas Eve, Memorial Sloan Kettering and the wider cancer community lost a beloved and brilliant doctor, Jimmie Holland, who died of cardiovascular disease at 89. Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer

Two of MSK's top brain experts reflect on how they care for people and recent advances in treatment.

… Monday, September 24, 2018 Summary MSK is improving the lives of people with brain cancer and helping their often stressed-out families. Two of MSK’s top brain cancer experts reflect on how they care for people and recent advances in treatment. There are few diseases as feared — or as challenging to